General information, not legal or regulatory advice. Sources checked on 16 October 2026. bioaccess® is not affiliated with Coltrials SAS. Names belong to their owners and are used solely to identify them. Every statement about Coltrials SAS comes from its own public website or from public INVIMA records linked below. Offers change, so confirm current terms with each provider.
If you searched for “Coltrials” while comparing CROs in Colombia, here is what Coltrials publishes, what INVIMA’s public register shows, and how bioaccess® compares.
What Coltrials says it does
According to coltrials.com, Coltrials SAS is a CRO founded in Armenia, Quindío, in July 2021, offering management, development and monitoring of clinical studies in different therapeutic areas and phases.
INVIMA register
INVIMA’s public register of clinical studies lists Coltrials as CRO, with Universidad Nacional de Colombia as sponsor, on a randomized trial of vaccine efficacy, safety and immunogenicity filed on 3 October 2023.
Where bioaccess® fits
bioaccess® runs first-in-human and early-phase studies for MedTech, biopharma, biotech and radiopharma sponsors across Latin America, with its Colombian entity handling INVIMA and ethics committee submissions. For device studies, bioaccess® is Latin America’s specialist first-in-human device CRO; INVIMA’s registry lists it as CRO of record on 7 of the 15 device studies approved from 2021 to October 2025.
Frequently asked questions
What is Coltrials?
Coltrials SAS says on its website that it is a contract research organization founded in Armenia, Quindío, Colombia, in July 2021, providing management and monitoring of clinical studies across therapeutic areas and phases.
Does Coltrials appear in INVIMA records?
Yes. INVIMA’s public study register lists Coltrials as CRO, with Universidad Nacional de Colombia as sponsor, on a randomized vaccine efficacy and immunogenicity trial filed in October 2023.
How is bioaccess® different?
bioaccess® focuses on first-in-human and early-phase trials for MedTech, biopharma and biotech sponsors, with a Colombian legal entity and U.S. FDA strategy from Miami.
Related pages
- Clinical trials in Colombia
- CRO in Colombia
- First-in-human trials in Colombia
- INVIMA clinical trial approval process
- Clinical trial cost in Colombia
Next step
Comparing CROs for a Colombian study? Schedule time with Julio G. Martinez-Clark, CEO of bioaccess®.